Application 020071

Type
NDA
Sponsor
ORGANON USA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DESOGENDESOGESTREL; ETHINYL ESTRADIOLTABLET;ORAL-210.15MG;0.03MGNoNo
002DESOGENDESOGESTREL; ETHINYL ESTRADIOLTABLET;ORAL-280.15MG;0.03MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020071-001DESOGENDESOGESTREL; ETHINYL ESTRADIOL0.15MG;0.03MGTABLET / ORAL-211992-12-10
N020071-002DESOGENDESOGESTREL; ETHINYL ESTRADIOL0.15MG;0.03MGTABLET / ORAL-281992-12-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-09-29 23:25 UTC2022-09N020071-001DESOGEN0.15MG;0.03MGTABLET / ORAL-211992-12-10e64feba35796…
2022-09-29 23:25 UTC2022-09N020071-002DESOGEN0.15MG;0.03MGTABLET / ORAL-281992-12-10e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020071-001DESOGEN0.15MG;0.03MGTABLET / ORAL-211992-12-10cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020071-002DESOGEN0.15MG;0.03MGTABLET / ORAL-281992-12-10cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N020071-001DESOGEN0.15MG;0.03MGTABLET / ORAL-211992-12-10a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N020071-002DESOGEN0.15MG;0.03MGTABLET / ORAL-281992-12-10a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
54670SUPPL2018-06-21
54628SUPPL2018-06-20
49419SUPPL2017-08-15
49325SUPPL2017-08-10
21106SUPPL2007-06-14
12178SUPPL2007-06-12
21105SUPPL2004-08-11